EUVIMEDAtrasti EUVIMED
Open access · CC BY-NC-ND 4.0

Single Centre Experience With the Balloon‐Expandable Myval Transcatheter Aortic Valve System in Patients With Bicuspid Anatomy: 1 Year Follow‐Up

Balázs Magyari, Bálint Kittka, Ilona Goják, Gábor Kasza, Kristóf Schönfeld, László Botond Szapáry, Mihály Simon, Rudolf Kiss, Andrea Bertalan, Edit Várady, István Szokodi, Iván Horváth

Catheterization and Cardiovascular Interventions · 2026-07 · 108 (1) · 144-162

DOI: 10.1002/ccd.70640 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, published online on 2026-04-23. Written by Balázs Magyari and 11 co-authors. Institution: Heart Institute, Medical School, University of Pécs, Pécs, Hungary. Major MEDLINE topics: Bicuspid Aortic Valve Disease, Heart Valve Prosthesis, Aortic Valve, Transcatheter Aortic Valve Replacement. 15 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Research, Development, and Innovation Office of Hungary.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve (BAV) anatomy remains challenging due to anatomical complexity and limited trial data. New‐generation balloon‐expandable valves, such as Myval, require further evaluation in this subgroup.

Aims

To report 1‐year VARC‐3 outcomes following TAVI procedure with the Myval transcatheter heart valve (THV) in BAV anatomy.

Methods

From December 2019 to July 2023, 52 consecutive BAV patients at moderate‐to‐high surgical risk or deemed unsuitable for surgery underwent TAVI with the Myval THV. Outcomes, assessed per VARC‐3 definitions, were compared to 217 trileaflet aortic valve (TAV) patients in unmatched and propensity score‐matched cohorts.

Results

At 1 year, BAV and TAV patients showed no significant differences in all‐cause mortality (3.9% vs. 10.2%, p = 0.185), cardiac mortality (0% vs. 2.3%, p = 0.587), or stroke (3.9% vs. 2.8%, p = 0.654) regarding an unmatched comparison. In the matched analysis, all‐cause mortality and stroke were 3.9% and 1.9%, respectively, with no cardiac deaths. Endocarditis was rare (1.9% vs. 1.4%, p = 0.579); no valve thrombosis occurred. At 1 year, 94% of matched patients were in NYHA class I. Echocardiographic parameters remained stable; no moderate/severe paravalvular regurgitation was observed in BAV patients. Kaplan–Meier analysis revealed no differences in survival or composite outcomes. Technical and device success rates exceeded 95%; early safety was limited by a high incidence of non‐vascular type 2–4 bleeding events. Based on the analyses, the relatively high postprocedural PPI rate (unmatched BAV vs. TAV: 34.0% vs. 30.4%, p = 0.429; matched: 34.0% vs. 24.0%, p = 0.274) is more likely attributable to patient‐related characteristics rather than device‐related complications, and remained unchanged following hospital discharge.

Conclusions

TAVI with the Myval THV in real‐world BAV patients is safe and effective with excellent hemodynamic performance at 1 year follow‐up. This may reinforce the use of this device in this anatomically complex population.

Subjects

MeSH terms (MEDLINE)

Bicuspid Aortic Valve DiseaseHeart Valve ProsthesisAortic ValveTranscatheter Aortic Valve ReplacementAortic Valve StenosisBalloon ValvuloplastyHumansFemaleMaleTreatment OutcomeProsthesis DesignTime FactorsAged, 80 and overRisk FactorsAgedRisk AssessmentRetrospective StudiesRecovery of FunctionFollow-Up Studies

Author keywords

TAVRannular ruptureballoon expendable transcatheter heart valvebicuspid aortic valveparavalvular leakpermanent pacemaker implantation

Authors and institutions

  • Heart Institute, Medical School, University of Pécs, Pécs, Hungary.
  • Szentágothai Research Centre, University of Pécs, Pécs, Hungary.
  • Department of Vascular Surgery, Medical School, University of Pécs, Pécs, Hungary.
  • Department of Medical Imaging, Medical School, University of Pécs, Pécs, Hungary.

Funding

  • National Research, Development, and Innovation Office of Hungary

Cite

APA

Magyari, B., Kittka, B., Goják, I., Kasza, G., Schönfeld, K., Szapáry, L. B., Simon, M., Kiss, R., Bertalan, A., Várady, E., Szokodi, I., & Horváth, I. (2026). Single Centre Experience With the Balloon‐Expandable Myval Transcatheter Aortic Valve System in Patients With Bicuspid Anatomy: 1 Year Follow‐Up. Catheterization and Cardiovascular Interventions, 108(1), 144-162. https://doi.org/10.1002/ccd.70640

Vancouver

Magyari B, Kittka B, Goják I, Kasza G, Schönfeld K, Szapáry LB, et al. Single Centre Experience With the Balloon‐Expandable Myval Transcatheter Aortic Valve System in Patients With Bicuspid Anatomy: 1 Year Follow‐Up. Catheterization and Cardiovascular Interventions. 2026;108(1):144-162. doi:10.1002/ccd.70640

BibTeX
@article{Magyari2026,
  author = {Magyari, Balázs and Kittka, Bálint and Goják, Ilona and Kasza, Gábor and Schönfeld, Kristóf and Szapáry, László Botond and Simon, Mihály and Kiss, Rudolf and Bertalan, Andrea and Várady, Edit and Szokodi, István and Horváth, Iván},
  title = {Single Centre Experience With the Balloon‐Expandable Myval Transcatheter Aortic Valve System in Patients With Bicuspid Anatomy: 1 Year Follow‐Up},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {108},
  number = {1},
  pages = {144--162},
  doi = {10.1002/ccd.70640}
}
Start for free →